Evidence map›Paper›PMID 22877734›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2012

PolyMorphine: an innovative biodegradable polymer drug for extended pain relief.

Roselin Rosario-Meléndez, Carolyn L Harris, Roberto Delgado-Rivera, Lei Yu, Kathryn E Uhrich

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Anticancer nanoparticulate polymer-drug conjugate.Bioengineering & translational medicine · 2016
    Review
  6. One-component nanomedicine.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Roselin Rosario-MeléndezDepartment of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Carolyn L Harris
Roberto Delgado-Rivera
Lei Yu
Kathryn E Uhrich
Rutgers, The State University of New Jersey · US

Funding

Local Modulation of Inflammation to Heal Cranial-facial Bone DefectsR01DE019926 · NIDCR · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI O'CONNOR, J PATRICK, RICCI, JOHN · 2009 to 2012
$2.5M
BIODEGRADABLE POLYMERIC PRODRUGSR01DE013207 · NIDCR · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI UHRICH, KATHRYN ELIZABETH · 2000 to 2009
$2.2M
NIDCR NIH HHS 1 R01DE019926-01NIDCR NIH HHS 5 R01DE0132070-09NIDCR NIH HHS R01 DE013207NIDCR NIH HHS R01 DE019926
6 · The paper itself

Abstract

Morphine, a potent narcotic analgesic used for the treatment of acute and chronic pain, was chemically incorporated into a poly(anhydride-ester) backbone. The polymer termed "PolyMorphine", was designed to degrade hydrolytically releasing morphine in a controlled manner to ultimately provide analgesia for an extended time period. PolyMorphine was synthesized via melt-condensation polymerization and its structure was characterized using proton and carbon nuclear magnetic resonance spectroscopies, and infrared spectroscopy. The weight-average molecular weight and the thermal properties were determined. The hydrolytic degradation pathway of the polymer was determined by in vitro studies, showing that free morphine is released. In vitro cytocompatibility studies demonstrated that PolyMorphine is non-cytotoxic towards fibroblasts. In vivo studies using mice showed that PolyMorphine provides analgesia for 3 days, 20 times the analgesic window of free morphine. The animals retained full responsiveness to morphine after being subjected to an acute morphine challenge.

Indexed as

3T3 CellsAnalgesics, OpioidAnimalsCell SurvivalDelayed-Action PreparationsMaleMiceMice, Inbred C57BLMorphinePainPolymersAnalgesics, OpioidDelayed-Action PreparationsMorphinePolymers

Identifiers

PMID22877734
PMCPMC3455147
OpenAlexW1976417452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.